Change of Address

BUFFERIN

NOVARTIS AG

Change Of Correspondence Address

The table below presents the data as entered.

Input Field	Entered
SERIAL NUMBER	71542436
REGISTRATION NUMBER	566190
MARK SECTION
MARK	BUFFERIN (stylized and/or with design)
CORRESPONDENCE SECTION (current)
ORIGINAL ADDRESS	BRISTOL-MYERS SQUIBB COMPANY 345 PARK AVE. NEW YORK New York 10154 United States
NEW CORRESPONDENCE ADDRESS
NEW ADDRESS	Mary F. Leheny Novartis 200 Kimball Drive Parsippany New Jersey United States 07054 973-503-8303 973-503-8304 mary.leheny@novartis.com
SIGNATURE SECTION
SIGNATURE	/Mary F. Leheny/
SIGNATORY NAME	Mary F. Leheny
SIGNATORY DATE	01/21/2008
SIGNATORY POSITION	Attorney for Applicant
FILING INFORMATION SECTION
SUBMIT DATE	Mon Jan 21 11:50:56 EST 2008
TEAS STAMP	USPTO/CCA-XXX.XXX.XXX.XX- 20080121115056232593-7836 4626-40087ae7a26ace688cc1 64e81e6cd241ba-N/A-N/A-20 080121114559882085

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.